Logo image
Clinical translation of controlled protein delivery systems for tissue engineering
Journal article   Open access   Peer reviewed

Clinical translation of controlled protein delivery systems for tissue engineering

Kara L. Spiller and Gordana Vunjak-Novakovic
Drug delivery and translational research, v 5(2), pp 101-115
01 Apr 2015
PMID: 25787736
url
https://europepmc.org/articles/pmc4311895View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Instruments & Instrumentation Life Sciences & Biomedicine Medicine, Research & Experimental Pharmacology & Pharmacy Research & Experimental Medicine Science & Technology Technology
Strategies that utilize controlled release of drugs and proteins for tissue engineering have enormous potential to regenerate damaged organs and tissues. The multiple advantages of controlled release strategies merit overcoming the significant challenges to translation, including high costs and long, difficult regulatory pathways. This review highlights the potential of controlled release of proteins for tissue engineering and regenerative medicine. We specifically discuss treatment modalities that have reached preclinical and clinical trials, with emphasis on controlled release systems for bone tissue engineering, the most advanced application with several products already in clinic. Possible strategies to address translational and regulatory concerns are also discussed.

Metrics

10 Record Views
40 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Instruments & Instrumentation
Medicine, Research & Experimental
Pharmacology & Pharmacy
Logo image